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IL-2 is a potent growth factor forT lymphocytesin vitro (1) . StimulationofT cells
by an antigen induces expression of IL-2 and/or IL-2-R L chain (Tac) and allows
proliferation ofT cell clones recognizing the particular antigen (2). The controlled
expression of IL-2 and IL-2-R L chain is thus speculated to be involved in antigen-
specific clonal expression of peripheralT cells and possibly in the development of
the T cell repertoire in the thymus (3, 4) . On the other hand, the deregulated ex-
pression of IL-2-R L chain is suggested to result in some T cell malignancies such
as adult T cell leukemia (ATL)1 (5-7) .
We have already reported some properties of transgenic mice bearing cDNA for
human IL-2 or IL-2-R L chain (8, 9) . The expression of these cDNAs is directed
by the constitutive H-2Kd promoter. Unstimulated spleen cells of the IL-2-R trans-
genic mice had -120 high affinity binding sites for IL-2 per cell, and proliferated
in vitro in the presence of exogenous human rIL-2, indicating the constitutive ex-
pression ofthe H chainofIL-2-R in unstimulated normal spleen cells (9) . We have
not observed any abnormality in this transgenic mouse, probably because endoge-
nous murine IL-2 has orders of magnitude weaker binding affinity to the human
IL-2-R than to the murine counterpart . By contrast, alopecia and pneumonia were
observed in the IL-2 transgenic micewhose sera contained 30-500 pMhuman IL-2
(8) . The IL-2 transgenic mice died within 1 yr after birth .
The constitutive expression of both human IL-2 and IL-2-R L chain in a single
transgenic animal could induce autocrine stimulation of lymphocytes, giving rise
to several abnormalities as follows . First, the antigen-independent activation of the
IL-2/IL-2-R pathway might cause polyclonal T cell proliferation, which results in
nonspecific immune responses including autoimmunity. Second, theconstitutive ex-
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pression ofIL-2 and its receptor in the thymus could somehow affect the T cell de-
velopment. Third, some kind of T cell leukemia/lymphoma-like ATL may arise in
the animal. Fourth, unusual expansion of the cells bearing the H chain of IL-2-R
may be observed.
To test these possibilities, we produced the hybrid mice that carried both human
IL-2 and IL-2-R L chain transgenes by crossing the two parental strains (8, 9). The
hybrid mice showed severe growth retardation and died by 4 wk of age. The spleens
of the mice contained an unusually large number of Thy-1+/CD3 - large granular
lymphocytes (LGL), which bore the elevated NK activity. In addition, we found
unexpectedly the selective loss of Purkinje cells in the cerebellum of the mice. How-
ever, we have not observed any signs of typical autoimmunity or incidence of leu-
kemia/lymphoma in the hybrid mice.
Materials and Methods
Animals.
￿
Construction and properties of the C57BL/6 mice bearing either human IL-2
or IL-2-R L chain cDNA driven by the H-2Kd promoter were described previously (8, 9).
The IL-2 and IL-2-R transgenic mice were crossed to produce the mice carrying both of
the transgenes. C57BL/6 mice were purchased from Shizuoka Laboratory Animal Co., Shi-
zuoka,Japan.
Flow Cytometry and Cell Sorting.
￿
Single cell suspensions were prepared from thymuses and
spleens as described (9). For staining, the following reagents were used: FITC-labeled anti-
Thy-1.2 mouse mAb (ICN ImmunoBiologicals, Lisle, IL), phycoerythrin (PE)-labeled anti-
CD4 mAb (anti-mouse L3T4 mAb; Becton Dickinson & Co., Mountain View, CA), FITC-
labeled anti-CD8 mAb (anti-mouse Lyt-2 mAb, Becton Dickinson & Co.), FITC-labeled
anti-human IL-2-R L chain mAb (antiTac mAb; reference 10), FITC-labeled anti-mouse
IL-2-R L chain mAb (clone 7D4; reference 11), FITC-labeled anti-mouse Mac-1 mAb (clone
Ml/70; reference 12), biotinylated anti-mouse CD3 mAb (clone 145.2C11; reference 13), and
PE-conjugated streptavidin (Becton Dickinson & Co.). Washed cells were stained with op-
timal concentrations of the fluorescein-labeled mAbs or the biotinylated mAb followed by
PE-streptavidin. Finally, cells were analyzed for two-color fluorescence by an Epics Profile flow
cytometer (Coulter Electronics, Inc., Hialeah, FL) with a single argon laser and logarithmic
intensity scales. 3 x 104 viable cells were analyzed in each sample. Dead cells were excluded
from analysis using a combination of low-angle and sideways light scatter. For cell sorting,
spleen cells ofthe hybrid mice were stained first with biotinylated anti-CD3 mAb and second
with PE-streptavidin and FITC-antiThy-1 mAb. They were sorted into the Thy-1'/CD3-
and Thy-1'/CD3' populations separately by using FACStar cell sorter (Becton Dickinson &
Co.). Reanalysis of the sorted cells revealed that the purity of each population was >95%.
Cytotoxicity Assay.
￿
5 x 106 target YAC-1 (H-2a), P815 (H-2d), or BW5147 (H-2k) cells were
labeled with 100 pCi "Cr (New England Nuclear, Boston, MA) for 45 min at 37 °C, and
extensively washed before use. Graded doses of effector spleen cells were added in duplicate
to 104 target cells in V-bottomed wells in a final volume of 200 pl. After incubation for 4 h
at 37°C, 100 id of supernatant was collected from each well to count the released radioac-
tivity. We determined spontaneous release of the radioactivity in wells without effector cells,
and the maximal release in wells in which cells were lysed by the addition of 0.1% Triton
X-100 (100 pl) for 30 min before collecting supernatant. Percent specific lysis was calculated
as: 100x (experimental - spontaneous release)/(maximal - spontaneous release).
Cell Cultures.
￿
Spleen cells from the normal, IL-2-R L chain transgenic, or hybrid mice
were cultured at 106 cells/ml in the complete RPMI 1640 medium (9) supplemented with
100 U/ml human rIL-2 (Takeda Chemical Industries, Osaka, Japan). On day 3, the cultures
were fed with fresh medium containing IL-2.
Southern Blot Analysis.
￿
DNAs from the liver and cultured spleen cells were prepared using
a nucleic acid extractor (Applied Biosystems Inc., Foster, CA). 10 wg ofeach DNA was digested
with restriction enzymes, subjected to electrophoresis on a 0.8% agarose gel, transferred toISHIDA ET AL .
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a nitrocellulose filter, and hybridized with 12P-labeled cDNA probes for the TCR genes . The
cDNA probes for CS (an EcoRI fragment ofdone 86T5) and for Cy (a Pvu II fragment
of clone pHDS203-205) were provided byDr.M . Davis (Stanford University, Stanford,CA)
and Dr. S. Tonegawa (Massachusetts Institute ofTechnology, Cambridge, MA), respectively.
Histological and Cytological Examinations .
￿
Organs were fixed in Bouin's solution . Sections
were stained routinely with hematoxylin and eosin . Lungs of the normal, IL-2-R L chain
transgenic, or hybrid mice were removed, and cut into fine pieces. They were suspended
in PBS containing 0.05% of collagenase (type IV; Sigma Chemical Co., St. Louis, MO) at
37°C and gently stirred by a magnetic stirrer for 5 min to release interstitial cells . The recov-
eries of single cells were 1.5-8.0 x 106 cells per hybrid mouse and <0.2 x 106 cells per normal
or IL-2-R L chain transgenic mouse . Morphology of hematopoietic cells was assessed after
depositing cells on microscope slides with a cytocentrifuge and staining with Wright and
Giemsa's stain .
Results
Expansion of Thy-I+/CD3- LGL in the Spleen ofHuman IL-2/IL-2-R L Chain Trans-
genic Mice . Themost striking cellular immunological abnormality found in the hy-
brid transgenic animals was the increase in the proportion and number of Thy-
1 +/CD3 - cells in the spleen, as shown in Fig . 1 . About 18% of the spleen cells of
the 2-wk-old hybrid mice were phenotypically Thy-1 +/CD3 - , whereas the age-
matched normal spleen did not contain a significant proportion of cells with this
phenotype . The Thy-1 +/CD3- cells were also rare in the spleen of the parental (IL-
2 or IL-2-R) transgenic mice . Another staining experiment showed that the spleen
of the 2 .5-wk-old hybrid mice contained a larger proportion of Thy-l + cells (N28%)
than that ofnormal mice (Table I) . However, the sum (N11%) ofCD4' and CD8+
cells was far less than the total Thy-1 + cells, indicating that there were a large
number of Thy-1 +/CD4- 8 - cells (N17%) in the spleen of the hybrid mice (Table
I) . As mature CD4' or CD8+ T cells always express the CD3 complex on their sur-
face (14), the two populations (Thy-1+/CD3- and Thy-l''/CD4-8- cells) detected in-
dependently in the spleen of the hybrid mice are most likely to be identical . The
hybrid micehad almost normal proportions of thymocyte subsets as compared with
the age-matched normalC57BL/6 mice, although thenumber ofthymocytes in the
hybrid mice was significantly smaller (Table I) .
We also performed morphological analysis on the hybrid spleen cells . As shown
in Table II, the spleen of the 2.5-wk-old hybrid mice contained a larger proportion
of LGL (N28%) as compared with the normal control (N7%) . It was then exam-
ined whether the expanded Thy-1 +/CD3- cells were morphologically LGL . We col-
lected the Thy-1+/CD3 - cells and Thy-l+/CD3' cells separately from the spleen of
the hybrid mice by using a FACS, and assessed the morphology of each population .
More than 95% of the Thy-1+/CD3 - cells were morphologically LGL (Fig . 2 A) .
FIGURE 1 .
￿
Expansion of Thy-1*/CD3- cells in the
spleen ofhumanIL-2/IL-2-R Lchain transgenic mice.
Whole spleen cells of the mice (2 wk old) were stained
with optimal concentrations ofFITC-antiThy-1.2 mAb
and biotinylated anti-mouse CD3mAbfollowed by PE-
streptavidin, and analyzed as described in Materialsand
Methods . Fluorescence intensities of cells are indicated
as dot matrices with logarithmic scales .1106
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TABLE I
Distribution of Lymphocyte Subsets in Human
IL-21IL-2-R L Chain Transgenic Mice
Mean percentages from three mice (2 .5 wk old) are shown t SDs. Mean num-
bers ofnucleated cells per organ of these mice were 4.5 ± 0.2 x 107/transgenic
thymus, 11 .3 t 0.9 x 107/normal thymus, 3 .6 ± 0.4 x 107/transgenic spleen,
and 4.3 f 0.9 x 107/normal spleen. Washed cells were stained with the fluo-
rescein-labeled antibodies and analyzed by flow cytometry.
By contrast, the Thy-1 +/CD3+ cells in the hybrid spleen were not LGL, but ordi-
nary lymphocytes without granules (Fig. 2 B).
Expanded Thy-1'/CD3- LGL Have the Strong NK Activity.
￿
When analyzed func-
tionally, spleen cells of the hybrid mice showed the markedly elevated NK activity
(Fig. 3). Not only a common NK target (YAC-1 cells [Fig. 3 A]), but also P815 cells
(Fig. 3 B) were killed by the hybrid spleen cells. Such NK activity of the hybrid
spleen cells is extraordinarily elevated as compared with normal spleen cells. Spleen
cells of the normal mice (including nude mice) at the age of 2-3 wk usually have
only marginal NK activity, and they can not kill P815 cells at all.
We next examined which of the two Thy-1+ populations (Thy-1 +/CD3- or Thy-1+/
CD3+ cells) in the spleen of the hybrid mice bore the strong NK activity. As shown
in Table III, the sorted Thy-1 +/CD3 - LGL showed very strong NK activity, whereas
the Thy-1 +/CD3 + cells, which represent ordinary T cells, had only negligible NK
activity.
TABLE II
Increased Proportion of LGL in the Spleen of
Human IL-21IL-2-R L Chain Transgenic Mice
Individual percentages and mean percentages t SDs are shown for the trans-
genic and normal mice, respectively. All of four transgenic and six normal
mice analyzed were 2.5 wk old.
' n = 6.
Organ T cell
Percent
Transgenic
of cells
Normal
Thymus CD4-8- 4.0 ± 0.1 2 .7 ± 0.5
CD4'8` 87 .1 t 0.8 85 .1 f 2.2
CD4'8- 7 .1 t 0.7 7 .7 f 0.8
CD4-8' 1 .8 t 0.3 4 .4 f 1 .8
Spleen Thy-1' 28.2 ± 3.9 11 .5 ± 0.1
CD4'8- 4.6 t 0.4 5 .2 ± 0.4
CD4-8' 6 .3 t 0.5 3 .2 f 0.2
Mouse
Differential
Granulocytes
count of
Monocytes
leukocytes in the spleen
Lymphocytes LGL
Transgenic
1 13 10 50 27
2 2 5 67 26
3 5 1 62 32
4 2 8 63 27
Normal' 7 t 4 4 t 2 82 ± 6 7 t 4FIGURE 2 .
￿
Morphology of expanded cells in human IL-2/IL-2-R L chain transgenic mice .
Thy-1'/CD3- cells (A) andThy-1'/CD3' cells (B) collected separately from the spleen of the trans-
genic mice . (C) Spleen cells of the transgenic mice enriched for Thy-1'/CD3- cells by the in vitro
culture with IL-2 . (D) Cells isolated from the lung of the transgenic mice.
Preferential IL-2-dependent Expansion of Thy-1+/CD3- LGL In Vitro from the Spleen of
Human IL-2/IL-2-R L Chain TransgenicMice. We next examined whether the spleen
cells of the hybrid mice were able to proliferate in vitro without any supplement
of growth factors . Though Thy-l'/CD3- LGL might have expanded in vivo by the
autocrine mechanism, none of the hybrid spleen cells could survive for more than
several days in the ordinary culture medium (data not shown) .
so
50
40
30
20
10
0
E : T Ratio
ISHIDA ET AL .
￿
1107
FIGURE 3 .
￿
Elevated NK activity of spleen cells ofhuman
IL-2/1L-2-R L chain transgenic mice . TheNK activity of
unfractionated spleen cells ofthe transgenic mice (") and
normal controls (A)wasexamined usingeither NK-sensitive
YAC-1 cells (A) or relatively NK-resistant P815 cells (B) in
various E/T ratios . Means of data from three mice (2 wk
old) are plotted with SDs (vertical bars) .1108
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TABLE III
NK Activity ofSpleen Cell Subpopulations of a
Human IL-21IL-2-R L Chain Transgenic Mouse
Thy-1'/CD3- and Thy-1'/CD3' cells were collected separately from the spleen
of the transgenic mouse, and analyzed as describedin Materialsand Methods.
Values are specific lysis, and are theaverage ofduplicate determinations. E/T
ratio was 12:1 . Mice analyzed were 2.5 wk old.
When supplemented with IL-2 (100 U/ml), however, Thy-1+/CD3 -4-8- cells pref-
erentially expanded in vitro among the whole spleen cells of the hybrid mice with
650% viable cell recovery of the input on day 6 (Fig. 4 C). The surface phenotype
of the in vitro expanded cells was indistinguishable from the in vivo expanded
Thy-1+/CD3- cells sorted from the hybrid spleen. They were also morphologically
LGL (Fig. 2 C). In contrast, when the spleen cells of the IL-2-R L chain transgenic
mice were cultured in vitro with IL-2, Thy-1+/CD3'4-8+ cells preferentially ex-
panded among the whole spleen cells (Fig. 4 B). Both of the two expanded popula-
mIL2RIL) hIL2RIL)
Thyl .2 CD3 CD4 CD8 Mac-1 (7D4) (CD26)
N.D.
N.D.
10 100 1 10 100 1 10 100 1 10 100 1 10 100 1
Fluorescence intensity
10 100 1 10 100
FIGURE 4.
￿
Phenotypical analysis of the spleen cells cultured with IL-2. Spleen cells from the
normal (A), IL-2-R L chain transgenic (B), or hybrid (C) mice were cultured in the presence
of 100U/ml IL-2 for6d. Cultured cellswere then analyzed with various mAbs by aflow cytom-
etry as describedin MaterialsandMethods. (Dashedlines) Controls that were notstained or stained
with only the second reagent; (m and h) mouse and human, respectively.
Effector cells
Target
YAC-1
cells
BW5147
Transgenic
Whole spleen cells 27 5
Thy-l'/CD3- spleen cells 49 6
Thy-l'/CD3' spleen cells 5 2
Normal
Whole spleen cells 0 1ISHIDA ET AL.
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tions of the hybrid and IL-2-R transgenic mice expressed human IL-2-R L chain
antigen, while endogenous murine IL-2-R L chain was almost undetectable (Fig.
4,Band C) . Normal (nontransgenic) spleen cells hardly grew in vitro in response to
IL-2, with <20% cells remaining viable on day 6, and they were mostly Thy-1 +/
CD3+ cells (Fig . 4 A) . These results suggest that Thy-1*/CD3 - LGL of the hybrid
mice might have intrinsic proliferative dominance over theMYTcells in response
to IL-2 .
Thy-1+/CD3-LGL in Human IL-2/IL-2-RL Chain Transgenie Mice Have Unrearranged
TCR Genes. The absence of theCD3 complex on the cell surface of the expanded
LGL in the hybrid mice suggests that they have neither the ao nor Y6 type of the
TCR. To confirm this observation, we analyzed the rearrangement of TCR genes
in theLGL of the hybrid mice that were enriched in vitro by the culture with IL-2 .
With the use ofthe C/3probe, only discrete germline bandsof the expected intensity
were detected in the Thy-1+/CD3- LGL-enriched hybrid spleen cells (Fig. 5, lanes
4), while germline bands with the decreased intensity were seen in the MY
cell-enriched spleen cells of the normal or IL-2-R transgenic mice (Fig . 5, lanes
2 and 3) . In addition, the Cy probe detected only germline bands in DNAs of liver
and the hybrid spleen cells (Fig. 5, lanes 1 and 4), whereas the rearranged 16-kb
Eco RI band (the uppermost one) was detected with the decreased intensity of 10.5-
and 10.8-kb Eco RI germline bands in DNAs of CD3' cell-enriched spleen cells
(Fig. 5, lanes 2 and 3) . These results indicate that the expanded LGL in the hybrid
mice have not rearranged the TCR genes and, as a consequence, do not express
TCR molecules on their surface .
FIGURE 5.
￿
Southern blot analysis ofTCR genes of the spleen cells cultured with IL-2 . DNAs
were isolated from the spleen cells cultured with IL-2 for 6 d . Origins of DNA are C57BL/6
liver (lanes 1), normal spleen cells (lanes 2), IL-2-R L chain transgenic spleen cells (lanes 3),
andhybrid spleen cells (lanes 4) . DNAwas digested with restrictionenzymes indicated . Southern
blot filters were hybridized with nick-translated, '"P-labeled cDNA probes for C,(3 and Cy . The
C ,y probe contains a portion of a Vy gene.1110
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FIGURE 6 . Growth retardation of
human IL-2/IL-2-R L chain trans-
genic mice . Left three transgenic and
right two normal mice were all 3 wk
old .
Other Abnormalities inHumanIL-21IL-2-RL Chain TransgenicMice.
￿
Thehybrid mice
always showed severe growth retardation, which became apparent -2 wk afterbirth
(Fig . 6) . In addition, their gait was disturbed or ataxic (i.e ., widebased and stag-
gering), and they fell down easily while walking . These hybrid mice died by 4wk
of age without exception .
To elucidate theprimary causeofthe early death of the hybrid mice, we analyzed
their tissues histologically . The3-wk-old hybrid mice showed severe interstitial pneu-
monia with focal infiltration of lymphocytes and other inflammatory cells (Fig . 7,
A and B) . The majority of infiltrating lymphocytes in the lung of the hybrid mice
were probably expanded Thy-1 +/CD3" LGL because cells collected from the col-
lagenase-treated lungs of the hybrid mice contained a large number ofLGL (Fig.
2 D) . The thymus and spleen of the 3-wk-old hybrid mice were far smaller than
thoseof the control mice, and theprofound lymphocyte depletions were found histo-
logically in the cortex of the thymus (Fig . 7, CandD) and in the red as well as white
pulp ofthe spleen (Fig . 7,EandF) . To our surprise, the3-wk-old hybrid mice selec-
tively lost 40-7017o ofPurkinje cells in the cerebellum without anysign ofinflamma-
tion (Fig. 7,GandH). This change mightbe associated with the ataxic gait ofthemice .
Histological studieson 2-wk-old hybrid mice didnot show evident sign ofdamage
in the thymus, spleen, and cerebellum although interstitial pneumonia was already
seen at this age . The results indicate that the damage in the thymus, spleen, and
cerebellum took place mainly after birth .
Discussion
Expansion ofNK Cells but notTCells inHumanIL-21IL-2-R L Chain Transgenic Mice.
￿
As
LGL that expanded in the spleen of the hybrid mice had the Thy-1+/CD3 -4 -8-
phenotype, the germline configuration ofTCR genes, and the strong NK activity,
they canbe regarded as classicalNK cells ofnonTcell lineage (15, 16). Recent studies
(9, 17, 18) showed that both LGL (or NK cells) and ordinary T cells (especially
CD8 + T cells) expressed the H chain of IL-2-R constitutively even at the resting
state. According to these findings,Tcells as well asNK cellsofthehybrid or IL-2-R
L chain transgenic mice are expected to express high affinity binding sites for IL-2
and to proliferate efficiently in response to IL-2 . Indeed, unstimulated spleen cells
of the IL-2-R L chain transgenic mice had -120 high affinity binding sites for IL-2ISHIDA ET AL .
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FIGURE 7 .
￿
Histological abnormalities in human IL-2/IL-2-R L chain transgenic mice . (A)
Histology of pneumoniain the transgenic mice . (B)Normal lung histology . (C) Histology ofthe
lymphocyte depletion in the cortex ofthe transgenic thymus. (D) Normal thymus histology. (E)
Histology of the lymphocyte depletion in the transgenic spleen . (F) Normal spleen histology .
(G) Histology of the selective loss of Purkinje cells in thecerebellum of the transgenic mice. (H)
Normal cerebellum histology . In C and D, c and m indicate cortex and medulla, respectively.
Mice analyzed were 3 wk old (140x, A andB ; 225x, C, D, G, and H ; and 110x, E and F) .111 2
￿
INTERLEUKIN 2/INTERLEUKIN 2 RECEPTOR TRANSGENIC MICE
per cell, and proliferated in vitro in response to the supplemented IL-2, yielding
the enriched population ofThy-l'/CD3'8' cells in 6 d ofthe culture (9) (Fig. 4 B).
Therefore, we first expected the expansion ofordinary Thy-1+/CD3+ T cells in the
hybrid micecarrying the IL-2 as well as IL-2-R L chain transgenes. Unexpectedly,
however, we could not detect the expansion of the ordinary T cells in the hybrid
mice, but instead observed the remarkably increased number ofThy-l'/CD3 - NK
cells in the spleen. The absence of nonspecific activation ofT cells was supported
by the finding that the sera ofthe hybrid mice did not contain a detectable amount
ofautoreactive antibodies as assessed by the immunohistochemicaltechnique (data
not shown). These results suggestthatthe NK cellsin the hybrid mice have apparent
advantages forselectiveproliferation as compared with ordinaryT cellsin thesemice.
The continuous activation ofthe IL-2/IL-2-R pathway in vivo in thehybrid mice
might have triggered negative feedback reactions in T cells but not in NK cells. It
is also possible that Tcells but not NK cells might require an additional signal for
their long-term proliferation in vivo, which could be transduced by the TCR com-
plex. T cells mayrequire agrowth factor other thanIL-2 for theirproliferation in vivo.
Since we constructed IL-2 or IL-2-R L chain transgenic mice by usingthe H-2Kd
promoter (8, 9), the transgenes should have been expressed early in the fetal stage
of the hybrid mice before the normal T cell development took place. This might
have caused the earlier extrathymic induction of NK cells in the hybrid mice than
in the normal controls, resulting in the dominant expansion of NK cells. We have
already reported that the in vitro IL-3/IL-2 culture induced CD3- LGL lines from
fetal liver cells while the same procedure induced CD3+ LGL lines from postnatal
spleen cells (19). These results further support the notion that the NK cells in the
hybrid mice might have been induced extrathymically in the fetal stage. The results
also suggest that functional IL-2-R H chains might be expressed on certain lym-
phoid cells at an early embryonic stage.
We observed the expansion of NK cells only in the IL-2/IL-2-R L chain hybrid
mice, but not in the IL-2 transgenic mice (8). These results clearly indicate that
the induction ofthe IL-2-R L chain is important for in vivo proliferation of NK
cells, which were reported to proliferate in vitro in the presence ofhigh concentra-
tions of IL-2 without the IL-2-R L chain expression (20-22).
We have never observed any incidence ofleukemia or lymphoma in the hybrid
mice. This may be partly due to the shortened life span of the hybrid mice.
HistologicalAbnormalitiesandActivation ofNK Cells.
￿
Every hybrid mouseexamined
showed typical interstitial pneumoniawith similartime course, suggesting that bac-
terial or viral infections are unlikely as the cause. The majority ofthe lymphocytes
infiltrating the lungsofthe hybrid mice were the activated NK cells. Sincethelungs
of the normal mice, which were administered with a high dose of human rIL-2,
were reported to be infiltrated with asialo-GMI' lymphoid cells (23), it is reason-
ableto assume that socalled IL-2-activated cells, such as the NK cells in the hybrid
mice, may have some affinity to the lung tissue. Alternatively, the NK cells might
have been activated and expanded in situ in the lung of the hybrid mice, because
we could easily detect mRNA ofhuman IL-2 in the lung of IL-2 transgenic mice
(8). In any case, interstitial pneumonia in thehybrid mice seems to be the primary
cause of their early death.
Wefoundthat the spleens ofthehybrid mice at the age of3 wk were smaller thanISHIDA ET AL.
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the normal ones, whichwas probably due to thelymphocyte depletion from theorgan.
As NK cells were reported to have a capacity to kill syngeneic lymphocytes (24),
ordinary lymphocytes in the spleen of the hybrid mice might have been killed by
the expanded Thy-1*/CD3- LGL with the elevated NK activity. Though the pro-
found lymphocyte depletion was also observed in the cortex of the thymus of the
3-wk-old hybrid mice, we could never detect the expansion of Thy-1+/CD3 - LGL
in the thymus of the mice (data not shown). This suggests that the mechanisms of
the lymphocyte depletion in the spleen and thymus of the mice might be different.
The stressed condition of thehybrid mice at the age of3 wk, just before their death,
might have resulted in the increased level of serum cortisone and the depletion of
cortisone-sensitive cells in the hybrid thymus cortex.
The ataxic movement ofthehybrid mice is most likely due to thedecreasednumber
of Purkinje cells. Though the histology of the cerebellum of the hybrid mice at the
age of 2 wk was almsot normal, we found that the hybrid mice at the age of 3 wk
selectively lost more than a half of Purkinje cells in their cerebella.
Patients treatedwith high-doserIL-2 occasionally showed psychological reactions
such as confusion (25), suggesting that IL-2 may have some effects on the central
nervous system. In fact, astrocytes or oligodendrocytes in the brain were shown to
proliferate and to mature in response to IL-2 (26, 27). Though we could not detect
mRNA of human IL-2 or IL-2-R L chain in the brain of the transgenic mice (8,
9), a localized expression of the transgenes could allow the activation of the IL-2-
responsive cells in the brain of the hybrid mice, which may somehow result in the
loss of Purkinje cells. Another possibility is that Purkinje cells may be extremely
susceptible to the NK-specific factors (28) produced by the increased Thy-1+/CD3-
LGL in the hybrid mice. At this stage, however, it is fair to say that we have no
reasonable explanation for the specific loss of Purkinje cells in the hybrid mice.
Summary
Transgenic mice expressing both human IL-2 andtheLchainof IL-2-R constitu-
tively had an unusual expansion of Thy-1+/CD3 -4-8- large granular lymphocytes,
which bore theelevated NK activity. Unexpectedly, the transgenic mice hadneither
T cell expansion nor autoreactive antibodies. The increase in number and activity
of NK cells seems to be responsible for both the severe interstitial pneumonia and
lymphocyte depletion in the spleen that we found in these transgenic mice. In addi-
tion, we foundtheselective loss of Purkinje cells in thecerebellum of themice, which
gave rise to their disturbed gait. All the transgenic mice died by 4 wk of age.
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